Chang A, Pelletier AN, McGuire DJ, Tsagiopoulou M, et al. PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy. Proc Natl Acad Sci U S A 2025;122:e2426935122.
PMID: 40906805